Recombinant SARS-CoV-2 NSP12 protein
CAT:
763-PKSV030327-02
Size:
100 µg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Recombinant SARS-CoV-2 NSP12 protein
Background:
The RdRp of SARS-CoV-2 is composed of a catalytic subunit known as nsp12 as well as two accessory subunits, nsp8 and nsp7. The structure of this RdRp has recently been reported; it is highly similar to the RdRp of SARS-CoV, a zoonotic coronavirus that spread into the human population in 2002. The nsp12 subunit contains an N-terminal nidovirus RdRp-associated nucleotidyltransferase (NiRAN) domain, an interface domain and a C-terminal RdRp domain. The RdRp domain resembles a right hand, comprising the fingers, palm and thumb subdomains that are found in all single-subunit polymerases. Subunits nsp7 and nsp8 bind to the thumb, and an additional copy of nsp8 binds to the fingers domain. Structural information is also available for nsp8–nsp7 complexes.Synonyms:
RNA-directed RNA polymerase; RdRp; SARS-CoV 2 nsp12UniProt:
P0DTC2Accession Number:
QHD43415.1Expression System:
E. coliTag:
N-GstSequence:
Asp4891-Val5212Endotoxin:
Please contact us for more information.Purity:
> 90 % as determined by reducing SDS-PAGE.Bioactivity:
Not validated for activityReconstitution:
Please refer to the printed manual for detailed information.Shipping Conditions:
This product is provided as lyophilized powder which is shipped with ice packs.Storage Conditions:
Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.Calculated Molecular Weight:
64.0 kDaObserved Molecular Weight:
60 kDaFormulation:
Supplied as solution form in PBS, pH7.5 or lyophilized from PBS, pH7.5
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.Species:
SARS-CoV-2